Laparoscopic lateral ovarian transposition

Treissman, Mark J.; Miller, Diane; McComb, Peter F.

doi:10.1016/s0015-0282(16)58344-7

Cited by 34 publications

(8 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reported indications for ovarian transposition include a spectrum of pelvic and non‐pelvic tumors: cervical cancer, Hodgkin's disease, cauda equine ependymoma and anorectal cancer . This diversity was shown in our study, with the most common indications being medulloblastoma ( n = 5), cervical cancer ( n = 4), rectal cancer ( n = 4) and musculoskeletal neoplastic disease ( n = 4).…”

Section: Discussionmentioning

confidence: 51%

Ovarian transposition before pelvic irradiation: Indications and functional outcome

Barahmeh

Masri

Badran

et al. 2013

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim: To investigate the indications and effectiveness of ovarian transposition before pelvic irradiation. Methods: This was a retrospective analysis of patients with malignancies who underwent ovarian transposition before pelvic irradiation. The collected data included age of patient, type and stage of cancer, details of irradiation treatment, and clinical and biochemical parameters of ovarian function during the period of follow-up. Results: Fourteen adult and four pediatric patients with different types of cancers underwent ovarian transposition during the study period. The common tumor types for the adult patients were cervical cancer (n = 4), rectal cancer (n = 4) and medulloblastoma (n = 3), and for pediatric patients was medulloblastoma (n = 2). The mean age for adult patients was 31 years (range, 21-40) and for pediatric patients was 7 years (range, 4-10). Of the adult patients, 10 had adjuvant chemotherapy and four had neoadjuvant chemotherapy added to their radiotherapy program. All pediatric patients received adjuvant chemotherapy. Thirteen of 14 (92.85%) adult patients had normal serum level of follicle-stimulating hormone (FSH; Յ12 IU/L) and E2 (>50 pg/mL). Only one patient had premature menopause. All pediatric patients demonstrated a normal serum level of FSH (<12) and E2 for their age at 3 and 6 months after completion of their treatment. The mean follow-up was 42 months (range, 34-50). Conclusion: Ovarian transposition is an effective procedure for the preservation of ovarian function. Young patients with non-hormone-dependent pelvic tumors should be offered a laparoscopic ovarian transposition before the start of pelvic radiotherapy.

show abstract

Section: Discussionmentioning

confidence: 51%

Ovarian transposition before pelvic irradiation: Indications and functional outcome

Barahmeh

Masri

Badran

et al. 2013

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…The published laparoscopic experience with ovarian transposition has been limited to few small series. 2,3,5,6,8,11,12 Reported complications of ovarian transposition are torsion of the ovarian vascular pedicle, 10 ureteric injury, bleeding, functional ovarian cysts, 10 and subsequent recurrence in transposed ovaries. 12,25 We aimed to evaluate the feasibility, the complication rates, and the functional outcome after laparoscopic ovarian transposition before pelvic irradiation in our patients younger than 45 years.…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic Ovarian Transposition Before Pelvic Irradiation: A Saudi Tertiary Center Experience

Al-Badawi

Al-Aker

Alsubhi

et al. 2010

Int J Gynecol Cancer

View full text Add to dashboard Cite

show abstract

“…According to this case report, normal serum FSH levels and menstrual cycles were restored 8 months after completion of pelvic RT. 33 …”

Section: Discussionmentioning

confidence: 99%

Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy

et al. 2016

View full text Add to dashboard Cite

Background Pelvic radiotherapy (RT) is a standard component of the management for patients with locally advanced rectal cancer or squamous cell carcinoma of the anus. Pelvic RT leads to permanent and irreversible ovarian failure in young women. This study aimed to determine the effectiveness of robotically assisted laparoscopic ovarian transposition (OT) before RT in women with rectal or anal cancer who wanted to preserve normal ovarian function. Methods The study reviewed the medical records of all patients treated at our institution from August 2009 to October 2014 who received robotically assisted laparoscopic OT for rectal or anal cancer before RT. Clinical and hormonal data were abstracted to determine ovarian function. Results The study identified 22 women with rectal (n = 20) or anal (n = 2) cancer. The median age of the women was 39 years (range 26–45 years). For one patient, OT was technically not feasible. The postoperative course was uneventful in all but one case. Follow-up data on ovarian function were unavailable for 3 patients. The median times from RT initiation to the last gynecologic or hormonal evaluation were 9 months (range 5–47 months) and 10.5 months (range 5–47 months), respectively. At the last gynecologic or hormonal follow-up visit, ovarian function was preserved in 12 (67%) of 18 evaluable patients, including 9 (90%) of 10 patients 40 years of age or younger and 3 (38%) of 8 patients older than 40 years (P = 0.07). Conclusions Robotically assisted laparoscopic bilateral OT is safe and can lead to preservation of ovarian function in two-thirds of patients with low gastrointestinal cancer undergoing pelvic RT. It should be considered in this setting, especially for women age 40 years or younger, to avoid premature menopause and its associated sequelae.

show abstract

Laparoscopic lateral ovarian transposition

Cited by 34 publications

References 5 publications

Ovarian transposition before pelvic irradiation: Indications and functional outcome

Ovarian transposition before pelvic irradiation: Indications and functional outcome

Laparoscopic Ovarian Transposition Before Pelvic Irradiation: A Saudi Tertiary Center Experience

Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy

Contact Info

Product

Resources

About